Brief: Sana Biotechnology Reports Third Quarter 2022 Results
Nov 2 (Reuters) - Sana Biotechnology Inc SANA.O :
* SANA BIOTECHNOLOGY REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS
AND BUSINESS UPDATES
* SANA BIOTECHNOLOGY INC- EXPECT CASH RUNWAY INTO 2025
* SANA BIOTECHNOLOGY INC- Q3 2022 CASH POSITION OF $511.6
MILLION
* SANA BIOTECHNOLOGY INC - QTRLY NET LOSS $0.45 PER SHARE
Source text for Eikon: ID:nGNXZjvCR
Further company coverage: SANA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sana Biotechnology
See all newsSana Biotechnology Inc reports results for the quarter ended June 30 - Earnings Summary
Sana Biotechnology Q2 adjusted loss narrows, beats estimates
Brief: Sana Biotechnology Q2 Adjusted EPS USD -0.13 Vs. IBES Estimate USD -0.15
Sana Biotechnology posts Q1 adjusted loss narrower than expected, extends cash runway
Brief: Sana Biotechnology Q1 Adjusted EPS USD -0.14 Vs. IBES Estimate USD -0.17